Inhibiting MDM2 oncogene expression as a novel approach to human cancer therapy.

被引：0
|
作者：
Wang, H
Agrawal, S
Zhang, R
机构：
[1] Hybridon Inc, Milford, MA USA
[2] Univ Alabama, Div Clin Pharmacol, Birmingham, AL 35294 USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2000年 / 67卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
OIIA4
引用
收藏
页码：141 / 141
页数：1
相关论文
共 50 条
  • [41] Genomic organisation of the human MDM2 oncogene and relationship to its alternatively spliced mRNAs
    Liang, HL
    Atkins, H
    Abdel-Fattah, R
    Jones, SN
    Lunec, J
    GENE, 2004, 338 (02) : 217 - 223
  • [42] MDM2 inhibition: an important step forward in cancer therapy
    Konopleva, Marina
    Martinelli, Giovanni
    Daver, Naval
    Papayannidis, Cristina
    Wei, Andrew
    Higgins, Brian
    Ott, Marion
    Mascarenhas, John
    Andreeff, Michael
    LEUKEMIA, 2020, 34 (11) : 2858 - 2874
  • [43] MDM2 SNP309 does not associate with elevated MDM2 protein expression or breast cancer risk
    Krekac, Daniel
    Brozkova, Kristyna
    Knoflickova, Dana
    Hrstka, Roman
    Muller, Petr
    Nenutil, Rudolf
    Vojtesek, Borivoj
    ONCOLOGY, 2008, 74 (1-2) : 84 - 87
  • [44] MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future
    Wang, Wei
    Albadari, Najah
    Du, Yi
    Fowler, Josef F.
    Sang, Hannah T.
    Xian, Wa
    McKeon, Frank
    Li, Wei
    Zhou, Jia
    Zhang, Ruiwen
    PHARMACOLOGICAL REVIEWS, 2024, 76 (03) : 414 - 453
  • [45] Alternative and aberrant messenger RNA splicing of the mdm2 oncogene in invasive breast cancer
    Lukas, J
    Gao, DQ
    Keshmeshian, M
    Wen, WH
    Tsao-Wei, D
    Rosenberg, S
    Press, MF
    CANCER RESEARCH, 2001, 61 (07) : 3212 - 3219
  • [46] Subcellular localization of Mdm2 expression and prognosis of breast cancer
    Hyung Seok Park
    Ji Min Park
    Seho Park
    Junghoon Cho
    Seung Il Kim
    Byeong-Woo Park
    International Journal of Clinical Oncology, 2014, 19 : 842 - 851
  • [47] Expression patterns of the p53 tumor suppressor gene and the mdm2 proto-oncogene in human meningiomas
    Mark J. Pykett
    John Landers
    Donna L. George
    Journal of Neuro-Oncology, 1997, 32 : 39 - 44
  • [48] Expression of heparanase, Mdm2, and erbB2 in ovarian cancer
    Ginath, S
    Menczer, J
    Friedmann, Y
    Aingorn, H
    Aviv, A
    Tajima, K
    Dantes, A
    Glezerman, M
    Vlodavsky, I
    Amsterdam, A
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2001, 18 (06) : 1133 - 1144
  • [49] MDM2 Expression and Regulation in Prostate Cancer Racial Disparity
    Wang, Guimin
    Firoz, Elnaz F.
    Rose, Amy
    Blochin, Elen
    Christos, Paul
    Pollens, Danuta
    Mazumdar, Madhu
    Gerald, William
    Oddoux, Carole
    Lee, Peng
    Osman, Iman
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2009, 2 (04): : 353 - 360
  • [50] Characterisation of a novel p53 down-regulated promoter in intron 3 of the human MDM2 oncogene
    Liang, HL
    Lunec, J
    GENE, 2005, 361 : 112 - 118
12345